IMDX vs QCOM · rev $1.9M vs P/E 16, rev $44.28B
Insight Molecular Diagnostics Inc. (IMDX) versus Qualcomm Incorporated (QCOM) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Latest reported IMDX revenue for 2024-12-31 was $1.9M. Net income was -$60.7M. Revenue was up 25.1% from 2023-12-31 to 2024-12-31. IMDX currently screens at market cap $0.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
IMDX currently screens at market cap $0. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Not investment advice. Open the IMDX and QCOM stock pages for the full models.
Not investment advice.